Neurology

Latest News

Image credit: onephoto - stock.adobe.com
Patient With MS Sues J&J Over ERISA Violation

February 14th 2024

After a patient with multiple sclerosis (MS) was forced to pay exorbitant out-of-pocket costs for a brand name medication when she could’ve gotten a generic for way less, the patient filed a class action complaint against her employer, Johnson & Johnson (J&J), for violating the Employee Retirement Income Security Act of 1974 (ERISA).

globe stethoscope medicine | Image credit: Planetz - stock.adobe.com
IQVIA Projects $192 Billion Loss for Originators by 2028 Thanks to Biosimilar, Generic Competition

January 18th 2024

Q&A With Dr Chelsee Jensen: Navigating FDA Approvals, Challenges in the Biosimilar Landscape
Q&A With Dr Chelsee Jensen: Navigating FDA Approvals, Challenges in the Biosimilar Landscape

January 14th 2024

brain colorful | Image credit: vegefox - stock.adobe.com
EC Approves First MS Biosimilar; Coherus Receives CRL for Neulasta Onpro Competitor

September 27th 2023

globe and an atom
Regulatory Updates From Around the Globe Provide Hope for Biosimilars

September 9th 2023

Video Interviews
Latest CME Events & Activities

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

June 27, 2024 | 1:00 PM & 7:00 PM ET

View More

Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Poly...

1.0 Credit / Neurology

View More

The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of ...

July 31, 2024 | 1:00 PM & 8:00 PM ET

View More

Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances

2.0 Credits / Neurology

View More

New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist

1.0 Credit / Neurology

View More

Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Care...

1.5 Credits / Neurology

View More

Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care

1.5 Credits / Neurology

View More

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases

View More

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

View More

More News

© 2024 MJH Life Sciences

All rights reserved.